« Previous
Next »
Subjects
- Insurance Coverage1
- Interleukin-6 -- antagonists & inhibitors1
- Janus Kinase Inhibitors -- therapeutic use1
- Multiple Sclerosis, Chronic Progressive -- drug therapy1
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy1
- Randomized Controlled Trials as Topic2
- Rituximab -- therapeutic use1
- Treatment Outcome1
- Tumor Necrosis Factors -- antagonists & inhibitors1
- United States2